Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexaria Bioscience (LEXX) Asset Utilization Ratio (2017 - 2025)

Historic Asset Utilization Ratio for Lexaria Bioscience (LEXX) over the last 12 years, with Q4 2025 value amounting to 0.1.

  • Lexaria Bioscience's Asset Utilization Ratio rose 9170.2% to 0.1 in Q4 2025 from the same period last year, while for Nov 2025 it was 0.1, marking a year-over-year increase of 9170.2%. This contributed to the annual value of 0.11 for FY2025, which is 3932.76% up from last year.
  • As of Q4 2025, Lexaria Bioscience's Asset Utilization Ratio stood at 0.1, which was up 9170.2% from 0.13 recorded in Q3 2025.
  • In the past 5 years, Lexaria Bioscience's Asset Utilization Ratio ranged from a high of 0.63 in Q2 2022 and a low of 0.03 during Q3 2022
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.08 (2023), whereas its average is 0.17.
  • Over the last 5 years, Lexaria Bioscience's Asset Utilization Ratio had its largest YoY gain of 76412.96% in 2022, and its largest YoY loss of 9488.05% in 2022.
  • Quarter analysis of 5 years shows Lexaria Bioscience's Asset Utilization Ratio stood at 0.54 in 2021, then plummeted by 90.79% to 0.05 in 2022, then surged by 75.69% to 0.09 in 2023, then tumbled by 38.72% to 0.05 in 2024, then surged by 91.7% to 0.1 in 2025.
  • Its last three reported values are 0.1 in Q4 2025, 0.13 for Q3 2025, and 0.08 during Q2 2025.